SCHEMBL22145207

SCHEMBL22145207

COc1ccc(C2(c3ccc(OC)cc3)C=Cc3c(c4ccccc4c4c5ccccc5n(-c5cccc(OC)c5)c34)O2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
HTT P42858 2/20 0.33
KMT2A Q03164 2/20 0.33
HSD17B10 Q99714 2/20 0.33
LMNA P02545 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
GSK3B P49841 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
EDNRA P25101 2/20 0.32
MAPT P10636 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
RPS6KB1 P23443 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
FGFR1 P11362 2/20 0.31
NTRK1 P04629 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22145208 0.95 SMN1; SMN2 (0.35) KDM4EMEN1ALDH1A1HPGDHTT
SCHEMBL22145205 0.93 EDNRA (0.34) KDM4EMEN1ALDH1A1HPGDHTT
SCHEMBL22145201 0.92 MAPT (0.36) KDM4EMEN1ALDH1A1HPGDHTT
SCHEMBL22145191 0.91 PPARG (0.32) PPARG
SCHEMBL22145250 0.91 KDM4E (0.36) KDM4EMEN1ALDH1A1HPGDHTT
SCHEMBL22145214 0.90 PPARG (0.40) MEN1ALDH1A1KMT2AHSD17B10LMNA
SCHEMBL22145210 0.90 ALDH1A1 (0.31) KDM4EMEN1ALDH1A1HPGDHTT
SCHEMBL22145135 0.89 EDNRA (0.36) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL22145204 0.87 L3MBTL1 (0.31) KDM4EMEN1ALDH1A1HPGDHTT
SCHEMBL22145193 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898636-B1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-08-30 EP disclosed
US-20220056039-A1 Indolonaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2022-02-24 US disclosed
WO-2020126032-A1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL, LTD. (IE) 2020-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220056039-A1 Indolonaphthopyrans TPH1, TPH2, IDO1 KDM4E 3356/4885MEN1 1845/4885ALDH1A1 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.